Status:
COMPLETED
Neurodevelopmental Therapy for Spastic Cerebral Palsy
Lead Sponsor:
University of Lahore
Conditions:
Cerebral Palsy
Spastic
Eligibility:
All Genders
2-6 years
Phase:
NA
Brief Summary
This study was conducted to find out the Effects of Neurodevelopment therapy (a rehabilitative program designed by Bobath) on Gross Motor Function and Postural Control in Children with Spastic Cerebra...
Detailed Description
A randomized controlled trial was conducted at Department of pediatric rehabilitation, Sher e Rabbani Hospital, Sheikhupura. Sample size was 66 and purposive sampling technique was adopted to collect ...
Eligibility Criteria
Inclusion
- • A diagnosed Spastic Cerebral Palsy (patient's diagnosis of CP confirmed by an expert pediatrician neurologist)
- Spastic CP
- No other severe abnormalities such as seizure
- Aged 2-6 years
- Both Genders
Exclusion
- Medical procedures likely to affect motor function such as botulinum toxin injections
- Orthopedic remedial surgery
- Mental retardation, or a learning disability.
Key Trial Info
Start Date :
June 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT05231538
Start Date
June 17 2021
End Date
December 31 2021
Last Update
February 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Lahore Teaching Hospital
Lahore, Punjab Province, Pakistan, 54000